Sulindac and its metabolites inhibit invasion of glioblastoma cells via down‐regulation of Akt/PKB and MMP‐2

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Cellular Biochemistry

• Publication date

  2005-02-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jcb.20312PMID 15546138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain‐derived neurotrophic factor regulates the expression of D1 dopamine receptors

  2007cited by this paper
• Matrix degrading metalloproteinases

  2005cited by this paper
• ARK5 Is a Tumor Invasion-Associated Factor Downstream of Akt Signaling

  2004cited by this paper
• High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma

  2004cited by this paper
• Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-β through Akt inhibition

  2004cited by this paper
• Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-β through Akt inhibition

  2004cited by this paper
• Akt Mediates Ras Downregulation of RhoB, a Suppressor of Transformation, Invasion, and Metastasis

  2004cited by this paper
• Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells

  2003cited by this paper
• The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines.

  2003cited by this paper
• Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma

  2002cited by this paper
• Celecoxib Induces Apoptosis by Inhibiting 3-Phosphoinositide-dependent Protein Kinase-1 Activity in the Human Colon Cancer HT-29 Cell Line*

  2002cited by this paper
• Selective cyclooxygenase‐2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells

  2002cited by this paper
• PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation.

  2002cited by this paper
• Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells.

  2001cited by this paper
• Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.

  2001cited by this paper
• Inhibitory Effect of Selenite on Invasion of HT1080 Tumor Cells*

  2001cited by this paper
• Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.

  2001cited by this paper
• Proteases in invasion: matrix metalloproteinases.

  2001cited by this paper
• Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production.

  2001cited by this paper
• Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1.

  2000cited by this paper
• ets-2 Is a Target for an Akt (Protein Kinase B)/Jun N-Terminal Kinase Signaling Pathway in Macrophages ofmotheaten-viable Mutant Mice

  2000cited by this paper
• Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt.

  2000cited by this paper
• Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer

  2000cited by this paper
• The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

  2000cited by this paper
• Chemoprevention of colorectal cancer.

  2000cited by this paper
• Cellular survival: a play in three Akts.

  1999cited by this paper
• Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas

  1999cited by this paper
• The role of cyclooxygenases in inflammation, cancer, and development

  1999cited by this paper
• Chemoprevention of colorectal cancer.

  1999cited by this paper
• The Transcription Factors Sp1, Sp3, and AP-2 Are Required for Constitutive Matrix Metalloproteinase-2 Gene Expression in Astroglioma Cells*

  1999cited by this paper
• Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.

  1999cited by this paper
• Activation of p38 Mitogen-Activated Protein Kinase by Sodium Salicylate Leads to Inhibition of Tumor Necrosis Factor-Induced IκBα Phosphorylation and Degradation

  1998cited by this paper
• Sulindac sulfide inhibits Ras signaling

  1998cited by this paper
• Regulation of cell death protease caspase-9 by phosphorylation.

  1998cited by this paper
• CREB Is a Regulatory Target for the Protein Kinase Akt/PKB*

  1998cited by this paper
• Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation.

  1998cited by this paper
• Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate

  1997influential reference
• Inhibition of Ultraviolet B-induced Activator Protein-1 (AP-1) Activity by Aspirin in AP-1-Luciferase Transgenic Mice*

  1997cited by this paper
• A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain

  1997cited by this paper
• Akt Signaling--Linking Membrane Events to Life and Death Decisions

  1997cited by this paper
• Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.

  1997cited by this paper
• Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.

  1997cited by this paper
• PI3K: downstream AKTion blocks apoptosis.

  1997cited by this paper
• Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

  1997cited by this paper
• Changing views of the role of matrix metalloproteinases in metastasis.

  1997cited by this paper
• Cell migration: a physically integrated molecular process.

  1996cited by this paper
• Mechanism of activation of protein kinase B by insulin and IGF‐1.

  1996cited by this paper
• Mechanism of action of anti-inflammatory drugs.

  1996cited by this paper
• Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

  1996cited by this paper
• Glioma invasion in the central nervous system.

  1996cited by this paper
• Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer.

  1996cited by this paper
• Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

  1995cited by this paper
• Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac.

  1995cited by this paper
• Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.

  1995cited by this paper
• The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis.

  1995cited by this paper
• Inhibition of mammary carcinogenesis by treadmill exercise.

  1995cited by this paper
• Inhibition of NF-kappa B by sodium salicylate and aspirin.

  1994cited by this paper
• Elevated Levels of Mr 92,000 Type IV Collagenase in Human Brain Tumors

  1993cited by this paper
• Incidence of cancer among patients with rheumatoid arthritis.

  1993cited by this paper
• Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.

  1993cited by this paper
• The matrix‐degrading metalloproteinases

  1992cited by this paper
• Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

  1986cited by this paper
• Interferon treatment of human neoplasia.

  1986cited by this paper
• Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo.

  1986cited by this paper
• Identification of the biologically active form of sulindac.

  1977cited by this paper
• Pathology of Tumors of the Nervous System.

  1964cited by this paper
• Chemoprevention of Colon Carcinogenesis by Sulindac , a Nonsteroidal Anti-inflammatory Agent 1

  year unknowncited by this paper

• NCAPH serves as a prognostic factor and promotes the tumor progression in glioma through PI3K/AKT signaling pathway

  2024cites this paper
• An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment

  2022cites this paper
• Corticosterone triggers anti-proliferative and apoptotic effects, and downregulates the ACVR1-SMAD1-ID3 cascade in chicken ovarian prehierarchical, but not preovulatory granulosa cells.

  2022cites this paper
• Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy.

  2021cites this paper
• Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy

  2019cites this paper
• Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs

  2019cites this paper
• CDCA5, Transcribed by E2F1, Promotes Oncogenesis by Enhancing Cell Proliferation and Inhibiting Apoptosis via the AKT Pathway in Hepatocellular Carcinoma

  2019cites this paper
• Stachydrine suppresses viability & migration of astrocytoma cells via CXCR4/ERK & CXCR4/Akt pathway activity.

  2018cites this paper
• Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas

  2018cites this paper
• Chemoprevention and Angiogenesis

  2017cites this paper
• Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro.

  2017cites this paper
• Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma

  2017cites this paper
• Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia‐glioma paradigm

  2017cites this paper
• Blocking COX-2 induces apoptosis and inhibits cell proliferation via the Akt/survivin- and Akt/ID3 pathway in low-grade-glioma

  2017cites this paper
• Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells?

  2016cites this paper
• Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells.

  2016cites this paper
• Developing a Novel Embryo–Larval Zebrafish Xenograft Assay to Prioritize Human Glioblastoma Therapeutics

  2016cites this paper
• ANTICANCER MECHANISM OF TOLFENAMIC ACID IN COLORECTAL CANCER

  2016cites this paper
• The role of TAM receptors in brain tumour cell signalling and behaviour

  2016cites this paper
• 基于MicroRNAs及其靶基因的化学预防药物对肿瘤抑制的作用

  2015cites this paper
• Anti-cancer effects and mechanism of actions of aspirin-like drugs in the treatment of gliomas

  2015cites this paper
• Mechanisms regulating glioma invasion.

  2015cites this paper
• Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.

  2014cites this paper
• Sj7170, a Unique Dual-function Peptide with a Specific α-Chymotrypsin Inhibitory Activity and a Potent Tumor-activating Effect from Scorpion Venom*

  2014cites this paper
• Scorpion Venom Activity and a Potent Tumor-activating-Chymotrypsin Inhibitory α with a Specific Sj 7170 , a Unique Dual-function Peptide Cell

  2014cites this paper
• Chemical Therapeutics A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt / mTORSignaling and Induction of Autophagy

  2013cites this paper
• Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme

  2013cites this paper
• A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt/mTOR Signaling and Induction of Autophagy

  2013cites this paper
• COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs

  2013cites this paper
• NSAIDs Inhibit Tumorigenesis, but How?

  2013cites this paper
• MicroRNA and Cancer Chemoprevention

  2013cites this paper
• microRNAs, New Players in Cancer Chemoprevention

  2013cites this paper
• Sulindac inhibits tumor cell invasion by suppressing NF-κB mediated transcription of microRNAs

  2012cites this paper
• Mechanism of neuroprotection in stroke-related models

  2012cites this paper
• Molecular and Cellular Complexity of Glioma Highlights on the Double-Edged-Sword of Infiltration Versus Proliferation

  2012cites this paper
• A sulindac analogue is effective against malignant pleural effusion in mice.

  2011cites this paper
• Predictive Capacity and Functional Significance of MicroRNA in Human Melanoma

  2011cites this paper
• Inhibition of Necl-5 (CD155/PVR) reduces glioblastoma dispersal and decreases MMP-2 expression and activity

  2011cites this paper
• Role of Nag-1 and p75NTR in non-steroidal anti-inflammatory drug inhibition of prostate cancer cell migration

  2011cites this paper
• FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide.

  2011cites this paper
• IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines

  2010cites this paper
• Sulindac Treatment and Fas Deletion: Effects on a Colon Cancer Mouse Model

  2009cites this paper
• The Cyclooxygenase Inhibitor Sulindac Sulfide Inhibits EP4 Expression and Suppresses the Growth of Glioblastoma Cells

  2009cites this paper
• Sulindac induces apoptotic cell death in susceptible human breast cancer cells through, at least in part, inhibition of IKKβ

  2009cites this paper
• Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.

  2009cites this paper
• Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice.

  2008cites this paper
• Celecoxib-induced degradation of T-cell factors-1 and -4 in human colon cancer cells.

  2008cites this paper
• Combination regimen with statins and NSAIDs: A promising strategy for cancer chemoprevention

  2008cites this paper
• Pro-apoptotic effect of nonsteroidal anti-inflammatory drugs on synovial fibroblasts

  2008cites this paper
• Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells.

  2007cites this paper
• Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.

  2007cites this paper
• High glucose enhances MMP‐2 production in adventitial fibroblasts via Akt1‐dependent NF‐κB pathway

  2007cites this paper
• Differential activity of sulindac metabolites against squamous cell carcinoma of the head and neck is mediated by p21waf1/cip1 induction and cell cycle inhibition

  2007cites this paper
• Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.

  2006cites this paper
• FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression.

  2006cites this paper
• Regulation of matrix metalloproteinase (MMP) gene expression by protein kinases.

  2006cites this paper
• Morphoproteomic demonstration of constitutive nuclear factor-kappaB activation in glioblastoma multiforme with genomic correlates and therapeutic implications.

  2006cites this paper
• Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapy.

  2006cites this paper
• Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.

  2006cites this paper